MGRX — MANGOCEUTICALS, INC.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1938046 ·
Last close
$0.47
Market Cap
$10.05M
52W High
$2.75
52W Low
$0.16
ADV30
1,288,463
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 68,757 44,215 -1,033,040 -1,312,653 14,172,795 228,688 1,648,969
Mar 2026 67,864 29,001 -3,126,326 -3,403,150 14,449,223 174,562 974,571
Dec 2025 94,360 47,475 -1,490,378 -2,769,567 16,089,573 1,486,338 890,568
Sep 2025 84,246 50,899 -7,542,926 -7,618,218 16,531,802 481,281 804,275

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,886,817
Investing CF
$0
Financing CF
$4,985,855
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.60
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-44,050,630
Inventory
$0
Receivables
$20,056
ST Investments
—
EBIT TTM
$-18,813,079
Pretax Income TTM
$-19,207,107
Interest Exp TTM
$394,028
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$315,227
EBITDA
$-12,097,073
Free Cash Flow
$1,268,902
Enterprise Value
$8,735,857
Total Cash
$228,688
Total Debt
$279,207
Shares Out
21,567,422
Trailing EPS
$-1.00
Book Value
$0.69
ROE
-95.1%
ROA
-47.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 456,021 -19,154,988 -20,642,994 16,089,573 890,568 15,200,547 -5,850,255
Dec 2024 615,873 -8,693,526 -8,706,145 15,370,511 1,425,463 13,946,129 -4,863,776
Dec 2023 731,493 -9,218,890 -9,212,417 1,050,793 276,039 774,754 -6,997,375
Dec 2022 8,939 -1,991,582 -1,998,055 1,003,287 389,257 614,030 -1,346,518

Peers — same industry

TickerNameMarket CapLastDaily %
CCM Concord Medical Services Holdings Ltd $10.14M $3.60 —
ADVB Advanced Biomed Inc. $10.54M $6.38 —
AMS AMERICAN SHARED HOSPITAL SERVICES $9.44M $1.42 —
XCRT Xcelerate, Inc. $8.69M $0.02 —
PFHO PACIFIC HEALTH CARE ORGANIZATION INC $12.80M $1.00 —

News headlines (Yahoo Finance, 1h cache)

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
2026-08-13 20:05 · Yahoo
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor
2026-07-30 14:35 · Yahoo
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
2026-08-05 20:05 · Yahoo
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
2026-08-04 20:05 · Yahoo
Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
2026-07-30 11:00 · Yahoo
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
2026-03-17 20:00 · Yahoo
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
2026-03-06 21:00 · Yahoo
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
2026-02-23 21:05 · Yahoo
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
2026-02-19 21:05 · Yahoo
Top Midday Decliners
2025-12-19 18:46 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.